Low dosis of alteplase, for ischemic stroke after Enchanted and its determinants, a single center experience
Abstract Background: Low-dose alteplase (LrtPA) has been shown not to be inferior to the standard-dose (SrtPA) with respect to death/disability. Objective: We aim to evaluate the percentage of patients treated with LrtPA at our center after the ENCHANTED trial and the factors associated with the u...
Main Authors: | Alejandro Michel Brunser, Enrico Mazzon, Gabriel Cavada, Eloy Mansilla, Alexis Rojo, Juan Almeida, Verónica Viviana Olavarría, Paula Muñoz-Venturelli, Pablo Manuel Lavados |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Neurologia (ABNEURO)
2020-12-01
|
Series: | Arquivos de Neuro-Psiquiatria |
Subjects: | |
Online Access: | http://www.scielo.br/pdf/anp/v78n11/1678-4227-anp-78-11-0681.pdf |
Similar Items
-
Who is in the emergency room matters when we talk about door-to-needle time: a single-center experience
by: Alejandro M. Brunser, et al.
Published: (2023-07-01) -
Effectiveness and Safety of Tecneplase vs. Alteplase in the Acute Treatment of Ischemic Stroke
by: Ángel Estella, et al.
Published: (2022-09-01) -
Mechanical thromb ectomy for acute ischemic stroke: systematic review and meta-analysis
by: Ananda Jessyla Felix Oliveira, et al.
Published: (2022-08-01) -
Temporal Trends of Intravenous Thrombolysis Utilization in Acute Ischemic Stroke in a Prospective Cohort From 1998 to 2019: Modeling Based on Joinpoint Regression
by: Verónica V. Olavarría, et al.
Published: (2022-04-01) -
Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials
by: Jian Huang, et al.
Published: (2024-12-01)